Great result here today, 2nd phase 2 trial in 2591 now successful hopefully a 3rd to come Q3.
Great to see PW paused until after FDA meeting, this meeting seem pivotal and a positive result in Angleman would bode well for PW anyway, perhaps better phase 2 trial design in play for PW after meeting.
Nice to hear Jon say that other future indications with 2591 straight to phase 2 trial.
Also great to hear Jon mention they have always thought Neu could fund x 2 trials alone in phase 3, at this point we could go alone on these x 2 PMS and PH and with end market conservatively x 4 of that of Rhettt
Staggering to see that share price is still under $30 really
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins, page-77
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.54 |
Change
0.100(0.80%) |
Mkt cap ! $1.559B | |||
| Open | High | Low | Value | Volume |
| $12.44 | $12.73 | $12.13 | $11.07M | 885.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1215 | $12.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.54 | 804 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |